ESSI

EssilorLuxottica is the only global company that controls what you see through and what sits on your nose. From the polycarbonate lens blank manufactured in a Thai prescription laboratory to the Ray-Ban Wayfarer sold in a LensCrafters store in Ohio, a single corporate entity captures value at every stage. This is not a typical consumer conglomerate. It is a closed-loop system where the company sells you the product, the distribution channel, and increasingly the prescription that makes you need the product in the first place.

The 2018 merger of Essilor and Luxottica combined the world's largest lens maker with the world's largest frame maker and retailer. At the time, regulators in the European Union, the United States, and Brazil approved the deal after extensive review. Seven years later, the structural consequences of that approval are becoming visible: the global eyewear industry now operates inside a framework that one company defines. Competitors do not set the rules of lens technology, frame licensing, or optical retail distribution. They respond to what EssilorLuxottica does.

The central analytical observation for this company is rarely articulated in standard financial coverage: EssilorLuxottica's moat is not brand strength or manufacturing scale considered separately. Its moat is the fact that it has made the eyewear value chain into a single vertically integrated pipeline where the economics of each stage subsidize the others. A competitor that wants to challenge Ray-Ban must build a frame business. A competitor that wants to challenge Varilux must build a lens chemistry business. A competitor that wants to challenge LensCrafters must build a retail network with 18,000 doors. A competitor that wants to challenge all three simultaneously, which is what the integrated model demands, must replicate a century of accumulated assets.

At a 2026 market capitalization of approximately EUR 91 billion and 2025 revenue of EUR 28.5 billion, the company combines scale with profitability that commodity consumer businesses rarely achieve: a gross margin above 60% and an EBITDA margin of 22.7%. The analytical question is not whether the moat exists. It is whether the moat is expanding into new categories, particularly smart eyewear and audiology, fast enough to justify the premium valuation the market continues to assign.